[Usefulness of rehabilitation in inflammatory myopathies].
Rehabilitation, for a long time not recommended, seems today to hold a prominent place within the therapeutic arsenal of inflammatory myopathies. The difficulty of its evaluation, apart from the low prevalence of these diseases, lies in a triple heterogeneity: first that distinguishing the different forms of inflammatory myopathies and the phase where they are active; second, that concerning the endpoint considered to assess the efficiency of the intervention; lastly, the diversity of the rehabilitation programs that can be undertaken. Between 1993 and 2016, about 30 studies estimating the rehabilitation of inflammatory myopathies have been published, among which five randomized controlled trials, four controlled trials, 15 open studies, and seven case reports. All these studies evidence the safety of rehabilitation and some show a significant improvement of the criteria estimating the activity of the disease, its functional impact or the impairment of quality of life and the limitation in daily life activities triggered by the disease. The rehabilitation, whether aerobic, anaerobic or mixed, must today systematically be associated with the pharmaceutic treatment proposed to patients affected by inflammatory myopathies. Other studies are necessary to optimize the rehabilitation methods, to understand their effects and action, and to quantify their impact and provide more trustworthy evidence.
DHUI2B, UMR974, UPMC, département de médecine interne et immunologie clinique, groupe hospitalier Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
Q
Q
Moyon
DHUI2B, UMR974, UPMC, département de médecine interne et immunologie clinique, groupe hospitalier Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: olivier.benveniste@aphp.fr.
O
O
Benveniste
D003131:Combined Modality Therapy; D003657:Decision Making; D015444:Exercise; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D051346:Mobility Limitation; D009220:Myositis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000534:rehabilitation*; D026741:Physical Therapy Modalities / Q000145:classification
D005938:Glucocorticoids
Inflammatory myopathies; Myopathies inflammatoires; Rehabilitation; Rééducation